Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

C4 Therapeutics (CCCC) Debt Ratio (2020 - 2023)

Historic Debt Ratio for C4 Therapeutics (CCCC) over the last 4 years, with Q2 2023 value amounting to 0.03.

  • C4 Therapeutics' Debt Ratio rose 2203.13% to 0.03 in Q2 2023 from the same period last year, while for Jun 2023 it was 0.01, marking a year-over-year increase of 1299.75%. This contributed to the annual value of 0.03 for FY2022, which is 2542.18% up from last year.
  • As of Q2 2023, C4 Therapeutics' Debt Ratio stood at 0.03, which was up 2203.13% from 0.03 recorded in Q1 2023.
  • In the past 5 years, C4 Therapeutics' Debt Ratio registered a high of 0.04 during Q3 2020, and its lowest value of 0.02 during Q2 2021.
  • Its 4-year average for Debt Ratio is 0.03, with a median of 0.02 in 2020.
  • Per our database at Business Quant, C4 Therapeutics' Debt Ratio tumbled by 5164.1% in 2021 and then skyrocketed by 2973.3% in 2023.
  • C4 Therapeutics' Debt Ratio (Quarter) stood at 0.03 in 2020, then fell by 15.42% to 0.02 in 2021, then increased by 25.42% to 0.03 in 2022, then grew by 3.41% to 0.03 in 2023.
  • Its Debt Ratio stands at 0.03 for Q2 2023, versus 0.03 for Q1 2023 and 0.03 for Q4 2022.